Physician profile
Grant Edward Garrigues
NPI 1609040575
$2,461,139.05
in general payments reported to CMS, 2019-2025
27 companies · $677K in 2025
The $677K reported for 2025 was more than what 99% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $181K · 2020: $330K · 2021: $245K · 2022: $261K · 2023: $389K · 2024: $378K · 2025: $677K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $750K · Consulting Fee: $642K · Travel and Lodging: $46K · Food and Beverage: $6,007 · Education: $93.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $749,634.44 |
| Consulting Fee | $642,435.32 |
| Travel and Lodging | $46,136.73 |
| Food and Beverage | $6,007.07 |
| Education | $93.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, Lp | $1,763,799.92 | 2019-2025 | Djo Surgical |
| Stryker Corporation | $269,739.78 | 2019-2025 | Aequalis Perform, Tornier Flex, Blueprint Patient Specific Instrumentation |
| Medical Device Business Services, INC. | $188,771.53 | 2019-2025 | Na, Dynacord, Inhance |
| Depuy Synthes Products, INC. | $70,891.42 | 2019-2024 | Na |
| Wright Medical Technology, INC. | $58,428.24 | 2019-2020 | |
| Insight Medical Systems, INC. | $37,276.83 | 2023-2024 | Arvis |
| Restor3d, INC. | $30,404.09 | 2022-2025 | |
| Pacira Pharmaceuticals Incorporated | $12,815.83 | 2019-2025 | Exparel, Iovera |
| Depuy Synthes Sales INC. | $9,518.84 | 2019-2025 | Gryphon Orthocord, Healix Knotless Peek, Bristow Latarjet |
| Orthofix Medical, INC. | $6,175.00 | 2023 | M6-C |
| Biopoly LLC | $4,942.21 | 2023-2025 | Biopoly Radial Head Implant |
| Azurmeds, INC. | $3,655.40 | 2021-2022 | |
| Medwest Associates | $1,247.95 | 2021-2022 | |
| Exactech, INC. | $684.38 | 2022 | |
| Bioventus LLC | $650.00 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $593.04 | 2020-2023 | Arthrex |
| Smith+Nephew, INC. | $426.72 | 2019-2024 | Lens 4k, Fast-Fix, Na |
| Breg, INC | $218.50 | 2020-2025 | |
| Zimmer Biomet Holdings, INC. | $180.80 | 2025 | Comprehensive |
| Davol INC. | $152.88 | 2023 | |
| Responsive Arthroscopy INC | $151.51 | 2019 | |
| Linvatec Corporation | $150.21 | 2020 | |
| Anika Therapeutics, INC. | $141.49 | 2023 | Revomotion, Ovomotion |
| Medacta USA, INC. | $98.35 | 2021 | |
| Catalyst Orthoscience | $24.13 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$823,280.78 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grant Garrigues listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.